Weekly Dosing of Malarone ® for Prevention of Malaria
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Malarone ®, which is a drug approved to
prevent malaria when taken daily, will still effectively prevent malaria if taken weekly.
Phase:
Phase 2
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command
Treatments:
Atovaquone Atovaquone, proguanil drug combination Proguanil